Protein expression of TIM-3 and its ligand, galectin-9, was quantified by digital imaging in 32 PCNSL patient tumor samples from a retrospective cohort we published recently 16 and in one postmortem normal brain sample (Figure 5A-B). Here, LGALS9 is linked to neoplasm.